Selected Publications

Goldenberg NA, Berkowitz SD, Betensky M, Holzhauer S, Ignjatovic V, Kiskaddon A, Schaufelberger D, Monagle P, Male C; Antithrombotic Trials Working Party of ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis & Hemostasis; Pediatric Antithrombotic Trials Leadership and Steering (Pedi-ATLAS) Group: Development of New Antithrombotic Drugs for Children (Part 1): Guidance from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis and the Pedi-ATLAS Group. J Thromb Haemost. April 2026 Notes: Epub ahead of print.

Whitworth H, Betensky M, Bhat RV, Al-Ghafry M, Amankwah EK, Biss TT, Brandao L, Chan A, Holzhauer S, Kiskaddon AL, Klaassen ILM, Monagle P, Raffini L, Revel-Vilk S, Sharathkumar A, Sochet AA, van Ommen CH, Male C, Goldenberg NA. : Systematic review on the design and methodology of the pediatric direct oral anticoagulant clinical trials for thrombosis prevention: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis. J Thromb Haemost. March 2026 Notes: Epub ahead of print.

Zia A, Whitworth H, Avila L, Klok FA, Alqahtani M, Gopalan D, Griffiths M, Rosovsky RP, Williams S, Babb TG, Rajpurkar M.: Clinically Relevant Outcomes for Research in Pediatric Pulmonary Embolism: Communication from the ISTH SSC Subcommittee on Pediatric/Neonatal Thrombosis and Haemostasis. J Thromb Haemost. 24(2): 766-780, Feb 2026.

Whitworth H, Branchford B, Faustino EV, Huibonhoa R, Kulkarni K, Raffini L, Rajpurkar M, Rodriguez V, Sochet AA, Valenti G, Zimowski KL, Jaffray J.: Research Priorities for Pediatric Venous Thromboembolism Prevention: Communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis. J Thromb Haemost. Feb 2026 Notes: Epub ahead of print.

Whitworth H, Wagner K, Avitabile CM, Blowey B, Costello RA, Davis JC, Davis DH, Ellison AM, Giglia TM, Himebauch AS, Houng K, Law CK, Mavroudis CD, Mercer-Rosa L, O’Byrne ML, Ravishankar C, Raffini LJ: Development, implementation, and evaluation of a pediatric pulmonary embolism clinical pathway and pulmonary embolism response team. Pediatr Crit Care Med 26(12): e1501-e1509, December 2025.

Kiskaddon A, Do N, Amankwah E, Witt DM, Ignjatovic V, Giglia T, Woods G, Whitworth H, Stock A, Goldenberg N: Risks of Incident Venous Thromboembolism, Recurrent Thromboembolism, and Use of Antithrombotic Therapies, Among Children with Congenital Heart Disease Undergoing Cardiac Surgery: A Global Multicenter Analysis of Real-World Data. J Thromb Haemost. 23(11): 3633-3639, November 2025.

Whitworth H, Wagner K, Zelinski A, DiCocco E, Goodwin-Davies AJ, Jordan R, Higginbotham M, O’Byrne M, Bailey LC, Raffini L, Rajpurkar M: A Novel Computable phENotype To Identify Pulmonary Embolism in chilDrEn: The CENTIPEDE Study. Thrombosis Research 253: 109385, September 2025.

Raffini L, Whitworth H: Weighing the evidence: apixaban for pediatric leukemia. Blood Advances 9(18): 4748-4749, September 2025.

Whitworth H, Raffini L: The balancing act after pediatric venous thromboembolism. Blood Advances 9(15): 3905-3906, August 2025.

Betensky M, Albisetti M, Biss T, Bhat RV, Brandão LR, Diacovo T, Monagle P, Raffini L, Revel-vilk S, van Ommen CH, Whitworth H, Goldenberg NA, Male C, on Behalf of the Antithrombotic Trials Working Party of the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis: Systematic Analysis of the Design, Methodology and Patient Population Characteristics of the Pediatric Direct Oral Anticoagulant (DOAC) Trials of Venous Thromboembolism Treatment. J Thromb Haemost 23(4): 1315-1331, April 2025.